Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When orexins meet cannabinoids: Bidirectional functional interactions
Fernando Berrendero, África Flores, Patricia Robledo
Biochemical Pharmacology (2018) Vol. 157, pp. 43-50
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexins/Hypocretins: Key Regulators of Energy Homeostasis
Edward Milbank, Miguel López
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 47
Orexin-A and endocannabinoids are involved in obesity-associated alteration of hippocampal neurogenesis, plasticity, and episodic memory in mice
Nicola Forte, Serena Boccella, Lea Tunisi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Regulation of Voluntary Physical Activity Behavior: A Review of Evidence Involving Dopaminergic Pathways in the Brain
Anaissa Ruiz-Tejada, Janet L. Neisewander, Christos S. Katsanos
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 333-333
Open Access | Times Cited: 22
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
In Vitro Signaling Properties of Cannabinoid and Orexin Receptors: How Orexin Receptors Influence Cannabinoid Receptor‐Mediated Signaling
Kawthar A. Mohamed, Robert B. Laprairie
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1
Marc Ten-Blanco, África Flores, Inmaculada Pereda-Pérez, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112925-112925
Open Access | Times Cited: 18
The short-chain fatty acid acetate modulates orexin/hypocretin neurons: A novel mechanism in gut-brain axis regulation of energy homeostasis and feeding
Nicola Forte, Brenda Marfella, Alessandro Nicois, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116383-116383
Open Access | Times Cited: 3
Orexins in apoptosis: a dual regulatory role
Simona Cavalu, Sameh Saber, Rabab S. Hamad, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease
Nicola Forte, Alba Clara Fernández-Rilo, Letizia Palomba, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 11
Asprosin, a novel therapeutic candidate for painful neuropathy: an experimental study in mice
Sibel Özcan, Muhammed Mirac Keleştemur, Munevver Gizem Hekım, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 3, pp. 325-335
Open Access | Times Cited: 9
Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives
Pilar Marcos, Rafael Coveñas
Applied Sciences (2023) Vol. 13, Iss. 13, pp. 7596-7596
Open Access | Times Cited: 5
Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity
Jazmine D. W. Yaeger, Kevin T. Krupp, Jason J. Gale, et al.
Medicine in Drug Discovery (2020) Vol. 8, pp. 100059-100059
Open Access | Times Cited: 14
Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats
Ali Mohammad Pourrahimi, Mehdi Abbasnejad, Saeed Esmaeili‐Mahani, et al.
Neuropeptides (2018) Vol. 73, pp. 25-33
Open Access | Times Cited: 14
Involvement of the Orexinergic System in Feeding
Pilar Marcos, Rafael Coveñas
Applied Sciences (2021) Vol. 12, Iss. 1, pp. 86-86
Open Access | Times Cited: 7
In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors
Hye Ji J. Kim, Ayat Zagzoog, Anna Maria Smolyakova, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 7
Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency
Ina Hammels, Erika Binczek, Inga Schmidt‐Soltau, et al.
Journal of Lipid Research (2019) Vol. 60, Iss. 8, pp. 1396-1409
Open Access | Times Cited: 6
Mutual assistance of nucleus accumbens cannabinoid receptor-1 and orexin receptor-2 in response to nicotine: a single-unit study
Reza Fartootzadeh, Hojjatallah Alaei, Parham Reisi
Research in Pharmaceutical Sciences (2021) Vol. 16, Iss. 2, pp. 173-181
Open Access | Times Cited: 5
Brain Regions and Neurotransmitter Systems Involved in Stress-Induced Analgesia
farzaneh Nazari-Srenjeh, Zahra Ghasemzadeh
The Neuroscience Journal of Shefaye Khatam (2024) Vol. 13, Iss. 1, pp. 104-115
Open Access
Orexin and cannabinoid systems modulate long-term potentiation of the hippocampus CA1 area in anesthetized rats.
Reza Fartootzadeh, Ramezan Ali Taheri, Mohammad Reza Nourani, et al.
PubMed (2024) Vol. 27, Iss. 4, pp. 461-465
Closed Access
Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease
Joan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5378-5378
Open Access
Effects of selective orexin receptor‐2 and cannabinoid receptor‐1 antagonists on the response of medial prefrontal cortex neurons to tramadol
Neda Hasanpour Razmanjani, Parham Reisi
Synapse (2022) Vol. 76, Iss. 7-8
Closed Access | Times Cited: 2
Hippocampal orexin-1 and endocannabinoid-1 receptors underlie the kainate-induced occlusion in theta-burst long- term potentiation
Giti Nasudi, Mahmoud Elahdadi Salmani, Narges Hosseinmardi, et al.
Neuropeptides (2022) Vol. 95, pp. 102263-102263
Closed Access | Times Cited: 2
The Effect of Orexin-2 and Endocannabinoid-1 Antagonists on Neuronal Activity of Hippocampal CA1 Pyramidal Neurons in Response to Tramadol in Rats
Vajihe Imanpour, Parham Reisi
Advanced Biomedical Research (2022) Vol. 11, Iss. 1, pp. 26-26
Open Access | Times Cited: 1
Distinct effects of orexin A on spontaneous and evoked synaptic currents in the rat nucleus tractus solitarius
Yoshiaki Ohi, Yūki Asai, Daisuke Kodama
Journal of Pharmacological Sciences (2022) Vol. 150, Iss. 4, pp. 244-250
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top